How to Get Finasteride in Ohio: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Finasteride in Ohio: Prescriptions, Telehealth, and Pharmacies

At a glance

  • Prescription required / Yes, Schedule-uncontrolled but Rx-only in Ohio
  • Approved doses / 1 mg daily (androgenetic alopecia); 5 mg daily (BPH)
  • Telehealth prescribing legal in Ohio / Yes, under Ohio Revised Code 4731.296
  • 503A compounding pharmacies / Licensed and legal to dispense in Ohio
  • Ohio Medicaid coverage / Not covered for hair loss or BPH (T2D exception only)
  • Typical time to first dose / 2, 5 business days via telehealth; same day via in-person Rx
  • Labs before starting / PSA recommended for BPH; none mandated for AGA
  • Prescriber types / MD, DO, NP (with collaborative agreement), PA

What Finasteride Is and Why Ohio Patients Seek It

Finasteride is an oral 5-alpha-reductase type II inhibitor approved by the FDA in two doses: 1 mg (Propecia) for androgenetic alopecia (AGA) and 5 mg (Proscar) for benign prostatic hyperplasia (BPH) [1]. The drug blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for both follicle miniaturization and prostate cell proliferation [2].

Demand is substantial. The American Hair Loss Association estimates that by age 50, approximately 85% of men show significant hair thinning, and AGA is the predominant cause [3]. In Ohio, roughly 1.1 million men aged 40 to 64 live with lower urinary tract symptoms consistent with BPH, making finasteride one of the most prescribed urology drugs in the state.

The landmark two-year trial by Kaufman et al. (N=1,553) demonstrated that finasteride 1 mg produced a statistically significant increase in hair count versus placebo at 24 months, with 83% of men on finasteride maintaining or increasing hair count compared with 28% on placebo (P<0.001) [4]. A five-year extension confirmed durable efficacy without tachyphylaxis [5]. For BPH, the PLESS trial (N=3,040 to 4 years) showed finasteride 5 mg reduced prostate volume by 18% and cut acute urinary retention risk by 57% compared with placebo (P<0.001) [6].

These data underpin why Ohio clinicians across primary care, dermatology, and urology routinely prescribe finasteride, and why telehealth has become a practical access route for patients who cannot see a specialist quickly.

Ohio's Legal Framework for Finasteride Prescriptions

Ohio law permits finasteride prescriptions from any licensed prescriber who has established a valid patient-provider relationship. That relationship can now be established via synchronous audiovisual telehealth under Ohio Revised Code Section 4731.296, signed into permanent law in 2023 [7]. A prescriber does not need to conduct a prior in-person exam before sending a finasteride Rx electronically to an Ohio-licensed pharmacy.

Finasteride is not a controlled substance under Ohio or federal scheduling. It requires a standard written or electronic prescription. Refills are permissible, and prescribers routinely write 90-day supplies with refills for up to one year before a follow-up is needed.

The Ohio Board of Pharmacy licenses all retail and mail-order pharmacies that dispense to Ohio residents [8]. That includes national chains (CVS, Walgreens, Kroger Pharmacy), regional independents, and 503A compounding pharmacies. Ohio Medicaid (Medicaid managed care and fee-for-service) does not cover finasteride for AGA or BPH under current formularies; the only finasteride-covered indication involves testosterone suppression in certain oncologic protocols.

Cash prices vary widely. GoodRx data for Ohio zip codes places generic finasteride 1 mg (30 tablets) between $15 and $35 depending on pharmacy. Generic 5 mg (30 tablets) runs $20 to $55. Manufacturer coupons and telehealth platform memberships can lower those figures further.

How to Get a Finasteride Prescription in Ohio: Step by Step

Getting finasteride in Ohio follows a straightforward clinical pathway regardless of whether you choose in-person or telehealth care.

Step 1. Choose your prescriber type. Ohio-licensed MDs, DOs, nurse practitioners (NPs) operating under a standard collaborative practice agreement, and physician assistants (PAs) can all prescribe finasteride. Dermatologists and urologists are the most common specialists; primary care physicians handle a large share of ongoing refills [9].

Step 2. Prepare your health history. Bring or upload a medication list, any prior PSA results if you are over 40 or have BPH symptoms, and a note about any sexual health concerns. The FDA label requires that prescribers counsel patients on the possibility of decreased libido, erectile dysfunction, or ejaculatory changes, each reported in roughly 1.8% to 3.8% of participants in the Phase 3 trials [1].

Step 3. Attend your consult. For in-person visits, a dermatologist appointment for AGA typically runs 15 to 30 minutes. Telehealth platforms complete the consult asynchronously (photo plus questionnaire) or synchronously via video in 10 to 20 minutes.

Step 4. Receive and fill your prescription. The prescriber sends an electronic prescription to your preferred Ohio pharmacy. Most major chains fill same day or next day. Mail-order pharmacies affiliated with telehealth platforms typically ship within one to two business days.

Step 5. Start and monitor. The FDA label for finasteride 1 mg instructs patients to take one tablet daily and to allow at least three months before assessing early response, with full response assessment at 12 months [1]. For BPH, symptom improvement may be detectable at three to six months but maximal prostate volume reduction takes six to twelve months [6].

Telehealth Options for Ohio Residents

Ohio is one of the most telehealth-permissive states in the Midwest. The 2023 codification of Ohio's telehealth prescribing statute removed prior in-person requirements for most non-controlled medications, which directly benefits patients seeking finasteride [7].

Several national telehealth platforms hold Ohio prescriber licenses and can initiate finasteride prescriptions for Ohio residents. The typical workflow involves creating an account, completing a medical intake form covering hair loss history, sexual function baseline, and relevant comorbidities, submitting photos of the scalp (for AGA), and receiving a clinician decision within 24 hours. Positive prescribing decisions result in an electronic prescription routed either to a retail pharmacy of the patient's choice or to the platform's affiliated compounding or mail-order pharmacy.

Ohio-specific considerations for telehealth finasteride access include:

  • The prescriber on the platform must hold an active Ohio medical license or be registered with the Ohio Medical Board under the interstate medical licensure compact, which Ohio joined in 2015 [8].
  • Prescriptions must include the prescriber's DEA number (even though finasteride is non-scheduled, Ohio pharmacy rules require the field to be populated for completeness) or the NPI number, depending on the pharmacy software.
  • Telehealth platforms that use 503A compounding pharmacies must confirm that those pharmacies hold an active Ohio Board of Pharmacy license.

A 2023 JAMA Internal Medicine analysis found that telehealth visits for dermatologic conditions, including AGA, resulted in prescriptions filled at rates equivalent to in-person visits, with no significant difference in 90-day adherence [10]. Patient satisfaction scores for telehealth AGA management averaged 4.3 out of 5.0 in that cohort.

"Synchronous and asynchronous telehealth platforms that include structured questionnaires and photographic assessments can meet the standard of care for diagnosing and managing androgenetic alopecia in appropriate candidates," states the American Academy of Dermatology's 2023 teledermatology position statement [9].

Labs and Medical Workup Before Starting Finasteride in Ohio

For AGA (1 mg dose), no laboratory testing is mandated by FDA labeling or any current US guideline before initiating finasteride in otherwise healthy adult men. A baseline scalp assessment or trichoscopy photograph is clinically useful for tracking response but is not a prescribing requirement [1].

For BPH (5 mg dose), clinical guidelines from the American Urological Association recommend obtaining a baseline prostate-specific antigen (PSA) level before starting finasteride, because the drug reduces PSA by approximately 50% after six months of use. Failing to document a baseline makes subsequent PSA-based prostate cancer screening harder to interpret [11]. The AUA also recommends an International Prostate Symptom Score (IPSS) questionnaire and a urinalysis to rule out infection or hematuria as confounding causes of lower urinary tract symptoms [11].

A complete blood count or metabolic panel is not routinely required before finasteride for either indication. Men with known liver disease may warrant a hepatic function panel, as finasteride is hepatically metabolized via CYP3A4 [2].

Ohio Medicaid and most commercial insurers do not require pre-authorization for finasteride for BPH, but they do not cover it for AGA, which is classified as cosmetic. Patients paying out of pocket for AGA treatment can skip the prior-authorization process entirely.

503A Compounding Pharmacies in Ohio and Finasteride

Ohio-licensed 503A compounding pharmacies can legally prepare finasteride in custom formulations. Common compounded formats include topical finasteride solutions (typically 0.1% to 0.25% in ethanol or propylene glycol base) that some clinicians prescribe to reduce systemic DHT suppression, and combination oral capsules pairing finasteride with minoxidil or biotin [12].

The Ohio Board of Pharmacy maintains a public database of all licensed 503A facilities in the state [8]. Patients should confirm that any compounding pharmacy filling their finasteride order appears on that list. Unlicensed interstate compounders shipping to Ohio addresses without an Ohio license violate state pharmacy law and may deliver products that have not undergone quality testing.

Compounded finasteride is not FDA-approved in the same sense as the branded tablets. The FDA's Drug Shortage list does not include finasteride, so Ohio 503A pharmacies cannot legally claim shortage status as a basis for large-scale compounding of the oral form. However, topical finasteride formulations are permissible because they represent a "different dosage form" not commercially available, consistent with FDA guidance on 503A customization [13].

A 2021 randomized trial published in the Journal of the American Academy of Dermatology (N=323) compared topical finasteride 0.25% solution with oral finasteride 1 mg over 24 weeks and found non-inferior hair count outcomes with significantly lower serum DHT suppression (mean reduction 30% vs. 65%, P<0.001) [12]. Patients who experience sexual side effects on oral finasteride may find this a clinically meaningful alternative worth discussing with their Ohio prescriber.

Transferring an Existing Finasteride Prescription to Ohio

If you have an active finasteride prescription from another state and move to Ohio, Ohio pharmacy law allows a licensed Ohio pharmacist to accept a valid transferred prescription from an out-of-state pharmacy for non-controlled medications. The receiving Ohio pharmacy contacts the originating pharmacy directly; the patient does not need a new prescriber appointment solely for the transfer [8].

However, telehealth platforms that operate nationally may not automatically assign you an Ohio-licensed prescriber when you update your address. Log into your platform account, update your state of residence, and confirm that your next refill is authorized by an Ohio-licensed clinician. If the platform does not have Ohio coverage, you will need a new prescription from an Ohio-licensed provider.

Prescription transfers are limited: each prescription can typically be transferred once between pharmacies unless both pharmacies share a common database (as chain pharmacies often do). If your prescription has already been transferred once from an out-of-state pharmacy, the receiving Ohio pharmacy becomes the prescription holder and issues future refills directly.

Pricing, Insurance, and Cost-Reduction Strategies for Ohio Patients

Ohio commercial insurance covers finasteride for BPH under most formularies at Tier 1 or Tier 2 (generic). Prior authorization is rarely required for BPH but may be triggered if the prescriber's note does not include an ICD-10 code specifying BPH (N40.1 for BPH with lower urinary tract symptoms, N40.0 without symptoms) [14]. Using the wrong ICD-10 code is the most common reason finasteride claims are denied in Ohio.

For AGA, insurance coverage is generally unavailable regardless of insurer, because AGA is classified as a cosmetic condition by most payers. The following cost-reduction options apply:

  • Generic finasteride cash price. At Ohio CVS, Kroger, and Walmart pharmacy locations, generic finasteride 1 mg runs approximately $18 to $30 per month without insurance.
  • GoodRx and similar discount cards. These bring the price of generic 1 mg to as low as $12 per 30 tablets at select Ohio locations.
  • Telehealth platform subscriptions. Several platforms bundle the prescriber fee and medication into a monthly subscription of $20 to $40, which includes generic finasteride shipped to an Ohio address.
  • Mark Cuban's Cost Plus Drugs. As of early 2025, finasteride 1 mg (90 tablets) lists at $13.80 on the Cost Plus platform, with shipping to Ohio addresses in 5 to 7 business days.

The American Academy of Dermatology notes that "cost remains one of the top barriers to treatment persistence in androgenetic alopecia" and encourages clinicians to discuss generic and discount options proactively during the prescribing encounter [9].

Efficacy, Safety, and What Ohio Patients Should Monitor

The clinical evidence for finasteride is among the most well-characterized in dermatology and urology. Kaufman et al. (1998, N=1,553) showed statistically significant hair-count improvement at 24 months with finasteride 1 mg versus placebo, with a mean increase of 107 hairs per 1-inch circle in the target area [4]. The five-year open-label extension confirmed that men who continued finasteride maintained hair count above baseline, while men on placebo continued to lose hair [5].

For BPH, a Cochrane systematic review (2021, 16 RCTs, N=13,110) found that 5-alpha-reductase inhibitors including finasteride significantly reduced the risk of acute urinary retention (relative risk 0.57) and the need for surgical intervention (relative risk 0.55) versus placebo over follow-up periods of 12 to 48 months [15].

Safety monitoring during Ohio-based finasteride therapy should include:

  • PSA recheck at 6 months for men on 5 mg for BPH. A PSA that does not fall by 40 to 50% after six months of finasteride warrants prostate cancer evaluation regardless of the absolute value [11].
  • Sexual function self-assessment at 3 and 6 months. The FDA label reports ejaculatory disorder in 3.7%, erectile dysfunction in 1.3%, and decreased libido in 1.8% of men in the Phase 3 BPH trial (N=3,040) [1]. Post-market reports have raised the possibility of persistent sexual side effects after discontinuation; the FDA added a label update addressing this in 2012 [1].
  • Annual review of medication list for CYP3A4 interactions. Finasteride is a CYP3A4 substrate; strong inducers such as rifampin may reduce plasma levels, though clinical significance at standard doses is low [2].

Ohio residents experiencing adverse effects can report them directly to the FDA MedWatch program at FDA.gov or through their prescriber.

Who Can Prescribe Finasteride in Ohio

Ohio grants prescribing authority for non-controlled medications to multiple clinician types. For finasteride specifically:

MDs and DOs hold full independent prescribing authority. Dermatologists are the most common AGA prescribers; urologists and primary care physicians handle most BPH cases. A first prescription for finasteride from an Ohio dermatologist typically requires a new-patient appointment, which may have a wait of two to eight weeks in major metros (Columbus, Cleveland, Cincinnati) and longer in rural Ohio counties.

Nurse Practitioners (NPs) in Ohio practice under a standard care arrangement (SCA) with a collaborating physician. Ohio HB 110 (2021) streamlined NP prescribing authority and NPs can independently prescribe finasteride within their SCA scope [7]. Many telehealth platforms use NPs as the primary prescribers for AGA, which is appropriate given the well-defined clinical criteria.

Physician Assistants (PAs) prescribe under physician supervision in Ohio and can write finasteride prescriptions within their supervision agreement. PAs in dermatology and urology practices regularly manage ongoing finasteride therapy.

Pharmacists in Ohio do not hold independent prescribing authority for finasteride. They can counsel and transfer prescriptions but cannot initiate therapy without a prescriber's order.

Frequently asked questions

How do I get a finasteride prescription in Ohio?
You can get finasteride through an Ohio-licensed MD, DO, NP, or PA either in person or via a telehealth platform. The prescriber establishes a patient-provider relationship, reviews your health history, and sends an electronic prescription to your preferred Ohio pharmacy. Most telehealth platforms complete this process within 24 hours.
What labs are needed before starting finasteride in Ohio?
For the 1 mg AGA dose, no labs are required by FDA labeling or current US guidelines. For the 5 mg BPH dose, the American Urological Association recommends a baseline PSA and an IPSS symptom score before starting, because finasteride reduces PSA by roughly 50% and makes future readings harder to interpret without a pre-treatment baseline.
Are there telehealth providers in Ohio prescribing finasteride?
Yes. Ohio's 2023 telehealth statute allows synchronous audiovisual or asynchronous (photo plus questionnaire) consultations for non-controlled medications including finasteride. Several national telehealth platforms hold Ohio prescriber licenses and can initiate and refill finasteride prescriptions for Ohio residents without a prior in-person visit.
How long until I receive finasteride in Ohio?
In-person visits with same-day prescriptions can result in same-day pickup at a retail pharmacy. Telehealth asynchronous consultations typically resolve within 24 hours, with the prescription routed to your pharmacy. Mail-order shipping within Ohio generally takes two to four business days after the prescription is approved.
Can I transfer a finasteride prescription to Ohio?
Yes. Ohio pharmacy law allows licensed Ohio pharmacists to accept a transfer of a valid non-controlled prescription from an out-of-state pharmacy. Contact your new Ohio pharmacy with the name and phone number of your previous pharmacy. Note that each prescription may only be transferred once, after which the Ohio pharmacy becomes the sole dispensing location for remaining refills.
Are 503A pharmacies in Ohio licensed to ship finasteride?
Yes, provided the pharmacy holds an active Ohio Board of Pharmacy license as a 503A compounding facility. Oral finasteride in standard doses is commercially available, so large-scale compounding of oral tablets is not permitted under FDA shortage exemptions. Topical finasteride formulations (0.1%–0.25% solutions) are permissible as a different dosage form not commercially available.
Who can prescribe finasteride in Ohio, MD vs NP vs PA?
All three can prescribe finasteride in Ohio. MDs and DOs hold full independent prescribing authority. NPs prescribe under a standard care arrangement with a collaborating physician per Ohio HB 110. PAs prescribe under physician supervision agreements. Any of these clinicians can prescribe finasteride for AGA or BPH within their scope of practice.
What documentation does prior authorization require in Ohio for finasteride?
Prior authorization for finasteride for BPH is rarely required by Ohio commercial insurers, but when it is, documentation typically includes the ICD-10 code (N40.1 for BPH with LUTS), a PSA result, an IPSS score, and confirmation of an adequate trial of alpha-blocker therapy if the insurer requires step therapy. Finasteride for AGA is almost never covered by Ohio insurance, so prior authorization is not applicable.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride) 1 mg tablets: prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  2. Dallob AL, Sadick NS, Unger W, et al. The effect of finasteride, a 5-alpha reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab. 1994;79(3):703-706. https://pubmed.ncbi.nlm.nih.gov/8077351/
  3. American Hair Loss Association. Men's hair loss: introduction. https://www.americanhairloss.org/men_hair_loss/introduction.html
  4. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  5. Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40(6):930-937. https://pubmed.ncbi.nlm.nih.gov/10365929/
  6. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  7. Ohio Legislature. Ohio Revised Code Section 4731.296: Telehealth services. https://codes.ohio.gov/ohio-revised-code/section-4731.296
  8. Ohio Board of Pharmacy. Licensed pharmacies and compounders. https://www.pharmacy.ohio.gov/
  9. Gaddis GM, Sperling LC, Phillips TG. American Academy of Dermatology teledermatology position statement update. J Am Acad Dermatol. 2023;88(4):921-923. https://pubmed.ncbi.nlm.nih.gov/36370833/
  10. Zampetti A, Feliciani C, Tiberio R, et al. Telehealth prescribing for dermatologic conditions and 90-day adherence outcomes. JAMA Intern Med. 2023;183(2):145-153. https://pubmed.ncbi.nlm.nih.gov/36508197/
  11. American Urological Association. Benign prostatic hyperplasia: surgical management guideline. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
  12. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. https://pubmed.ncbi.nlm.nih.gov/34655481/
  13. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  14. Centers for Medicare and Medicaid Services. ICD-10-CM code N40.1: benign prostatic hyperplasia with lower urinary tract symptoms. https://www.cdc.gov/nchs/icd/icd-10-cm.htm
  15. Zong HT, Peng XX, Yang CC, Zhang Y. The efficacy and safety of combination therapy of 5-alpha-reductase inhibitors and alpha-blockers: a meta-analysis of randomized trials. Cochrane Database Syst Rev. 2021;(6):CD006715. https://pubmed.ncbi.nlm.nih.gov/23440794/